The Impact of Churn on HIV Outcomes in a Southern United States Clinical Cohort Restricted; Files Only
Gopalsamy, Srinivasa Nithin (Spring 2022)
Abstract
Background. Persons with HIV (PWH) may experience a cycle of engaging and disengaging in care in a phenomenon designated as “churn.” While HIV churn is predicted to be more prevalent in the southern United States, it has not been well characterized in this region.
Methods. We conducted a retrospective cohort study involving PWH newly establishing care at a large, urban clinic in Atlanta, Georgia from 2012 to 2017 with follow-up data collected through 2019. The primary exposure was churn, defined as a ≥12-month gap between routine clinic visits or viral load measurements. We evaluated HIV metrics, clinical outcomes, and care continuum outcomes.
Results. Of 1303 PWH newly establishing care, 81.7% were male, 84.9% Black, and 200 (15.3%) experienced churn in 3.3 years of median follow-up time. The transmissible viremia (TV) rate increased from 28.6% pre-churn to 66.2% post-churn (p-value <.0001). The 122 PWH having TV on re-engagement had delayed time to subsequent VS (aHR 0.59, 95% CI 0.48 – 0.73), and PWH returning to care contributed disproportionately to the community viral load (CVL) (% of CVL / % of patients 1.96). Churn was not associated with increased AIDS-defining illness (aOR 0.61, 95% CI 0.35 – 1.07), mortality (aHR 1.00, 95% CI 0.66 – 1.50), subsequent churn (aOR 1.53, 95% CI 0.79 – 2.97) or loss to follow-up (aOR 1.04, 95% CI 0.60 – 1.79).
Conclusions. The rate of churn in a Southern clinic was high, and those who experienced churn had increased TV at re-entry and disproportionately contributed to the CVL without early clinical or care continuum consequence.
Table of Contents
Introduction........................................................1
Methods..............................................................6
Study Design and Participants.............................. 6
Cohort Assignment.............................................. 7
Exposure and Covariates.......................................8
Outcome Variables............................................... 8
Power Analysis................................................... 12
Statistical Analyses.............................................13
Results...............................................................14
General Characteristics.......................................14
HIV Metric Outcomes......................................... 15
Clinical and Care Continuum Outcomes...............17
Discussion......................................................... 19
General Characteristics.......................................19
HIV Metric Outcomes......................................... 20
Clinical and Care Continuum Outcomes............... 21
Limitations and Future Directions....................... 25
Conclusion.........................................................26
Figures and Tables..............................................27
References..........................................................37
About this Master's Thesis
School | |
---|---|
Department | |
Degree | |
Submission | |
Language |
|
Research Field | |
Palavra-chave | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
File download under embargo until 26 May 2028 | 2022-04-13 01:47:06 -0400 | File download under embargo until 26 May 2028 |
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|